Thirty-two year-old Evangeline Semark Lemoine was healthy until she developed deep vein thrombosis, a dangerous blood clot located in her leg, about one year ago. Lemoine says that blood clots have also been found in her lungs. She is now on a powerful blood thinner that interferes with her ability to carry on a normal lifestyle with her family, and finds even simple tasks challenging. Lemoine attributes her health problems to her use of Ocella, the generic version of Yasmin, and hopes that her lawsuit will help others. “I need to speak up and let other women know so that they might not have to go through what I went through," said Lemoine.
Lemoine is not alone in her claim against the manufacturers of Yaz, Yasmin and Ocella. Susan Galinis suffered a stroke while taking Yaz, and had to have part of her skull removed to relieve pressure caused by swelling. Galinis is also suing Bayer, manufacturer of Yaz.
As of October 15, approximately 150 lawsuits have been filed against the manufacturers of drospirenone-containing oral contraceptives. Drospirenone is a newer form of progestin. According to research recently published in the British Medical Journal, newer forms of progestin, including drospirenone, have been connected to a higher risk of blood clots than older forms of oral contraceptives.
No comments:
Post a Comment